Even when considered dichotomized variables, the expression of both biomarkers was significantly associated with a lack of complete tumor regression: 87% of YKL-40-positive cases and 86% c-Met-positive cases had a TRG2-5. The gene discussed is CHI3L1; the disease is neoplasm.